Typ-IV-Allergie auf injizierbares Triamcinolonacetonid
Crossref DOI link: https://doi.org/10.1007/BF03360662
Published Online: 2016-06-28
Published Print: 1999-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Leiter, U.
Gall, H.
Peter, R.-U.